Exelixis Inc Earnings Per Share (Diluted)
Exelixis Inc (EXEL) reported Earnings Per Share (Diluted) of $0.82 per share for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- Exelixis Inc earnings per share, diluted for the quarter ending 2026-07-03 was $0.82, a 26.15% increase year-over-year.
- Exelixis Inc earnings per share, diluted for the quarter ending 2026-04-03 was $0.79, a 43.64% increase year-over-year.
- Exelixis Inc earnings per share, diluted for the quarter ending 2025-10-03 was $0.69, a 72.50% increase year-over-year.
- Exelixis Inc earnings per share, diluted for the quarter ending 2025-07-04 was $0.65, a 15.58% decline year-over-year.
- Exelixis Inc earnings per share, diluted for fiscal 2026 was $2.78, a 57.95% increase from fiscal 2025.
- Exelixis Inc earnings per share, diluted for fiscal 2025 was $1.76, a 170.77% increase from fiscal 2023.
- Exelixis Inc earnings per share, diluted for fiscal 2023 was $0.65, a 16.07% increase from fiscal 2022.
- Exelixis Inc earnings per share, diluted for fiscal 2022 was $0.56, a 22.22% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-07-03 | $0.82 10-Q · filed 2026-08-05 | $1.60 10-Q · filed 2026-08-05 | ||
| 2026-04-03 | $0.79 10-Q · filed 2026-05-05 | |||
| 2026-01-02 | $2.78 10-K · filed 2026-02-10 | |||
| 2025-10-03 | $0.69 10-Q · filed 2025-11-04 | $1.90 10-Q · filed 2025-11-04 | ||
| 2025-07-04 | $0.65 10-Q · filed 2026-08-05 | $1.20 10-Q · filed 2026-08-05 | ||
| 2025-04-04 | $0.55 10-Q · filed 2026-05-05 | |||
| 2025-01-03 | $1.76 10-K · filed 2026-02-10 | |||
| 2024-09-27 | $0.40 10-Q · filed 2025-11-04 | $1.28 10-Q · filed 2025-11-04 | ||
| 2024-06-28 | $0.77 10-Q · filed 2025-07-28 | $0.88 10-Q · filed 2025-07-28 | ||
| 2024-03-29 | $0.12 10-Q · filed 2025-05-13 | |||
| 2023-12-29 | $0.65 10-K · filed 2026-02-10 | |||
| 2023-09-29 | $0.00 10-Q · filed 2024-10-29 | $0.38 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $0.25 10-Q · filed 2024-08-06 | $0.37 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $0.12 10-Q · filed 2024-04-30 | |||
| 2022-12-30 | $0.56 10-K · filed 2025-02-11 | |||
| 2022-09-30 | $0.23 10-Q · filed 2023-11-01 | $0.44 derived: net income ÷ weighted average shares · filed 2023-11-01 | $0.65 10-Q · filed 2023-11-01 | |
| 2022-07-01 | $0.22 10-Q · filed 2023-08-01 | $0.43 10-Q · filed 2023-08-01 | ||
| 2022-04-01 | $0.21 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.72 10-K · filed 2024-02-06 | |||
| 2021-10-01 | $0.12 10-Q · filed 2022-11-01 | $0.42 derived: net income ÷ weighted average shares · filed 2022-11-01 | $0.42 10-Q · filed 2022-11-01 | |
| 2021-07-02 | $0.30 10-Q · filed 2022-08-09 | $0.30 10-Q · filed 2022-08-09 | ||
| 2021-04-02 | $0.00 10-Q · filed 2022-05-10 | |||
| 2021-01-01 | $0.09 10-K · filed 2021-02-11 | $0.35 10-K · filed 2023-02-07 | ||
| 2020-10-02 | -$0.10 10-Q · filed 2021-11-02 | $0.26 10-Q · filed 2021-11-02 | ||
| 2020-07-03 | $0.21 10-Q · filed 2021-08-05 | $0.36 10-Q · filed 2021-08-05 | ||
| 2020-04-03 | $0.15 10-Q · filed 2021-05-06 | |||
| 2020-01-03 | $0.22 10-K · filed 2021-02-11 | $1.02 10-K · filed 2022-02-18 | ||
| 2019-09-27 | $0.31 10-K · filed 2021-02-11 | $0.80 10-Q · filed 2020-11-05 | ||
| 2019-06-28 | $0.25 10-K · filed 2021-02-11 | $0.49 10-Q · filed 2020-08-06 | ||
| 2019-03-29 | $0.24 10-K · filed 2021-02-11 | |||
| 2018-12-28 | $1.15 10-K · filed 2020-02-25 | $1.56 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.84 derived: net income ÷ weighted average shares · filed 2020-02-25 | $2.21 10-K · filed 2021-02-11 |
| 2018-09-29 | $0.41 10-K · filed 2020-02-25 | |||
| 2018-09-28 | $0.41 10-Q · filed 2019-10-30 | $0.69 derived: net income ÷ weighted average shares · filed 2019-10-30 | $1.05 10-Q · filed 2019-10-30 | $1.18 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-06-29 | $0.28 10-K · filed 2020-02-25 | $0.65 10-Q · filed 2019-07-31 | $0.77 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.03 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-03-31 | $0.37 10-K · filed 2020-02-25 | |||
| 2018-03-30 | $0.37 10-Q · filed 2019-05-01 | $0.49 derived: net income ÷ weighted average shares · filed 2020-02-25 | $0.75 derived: net income ÷ weighted average shares · filed 2020-02-25 | |
| 2017-12-29 | $0.12 10-K · filed 2019-02-22 | $0.38 derived: net income ÷ weighted average shares · filed 2020-02-25 | $0.49 10-K · filed 2020-02-25 | |
| 2017-09-30 | $0.26 10-K · filed 2019-02-22 | $0.37 10-Q · filed 2017-11-01 | ||
| 2017-09-29 | $0.26 10-Q · filed 2018-11-01 | $0.32 derived: net income ÷ weighted average shares · filed 2018-11-01 | $0.37 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $0.06 10-K · filed 2019-02-22 | $0.11 10-Q · filed 2017-08-02 | ||
| 2017-03-31 | $0.05 10-Q · filed 2017-05-01 | |||
| 2016-12-30 | $0.12 10-K · filed 2018-02-26 | -$0.28 10-K · filed 2019-02-22 | ||
| 2016-09-30 | -$0.04 10-K · filed 2018-02-26 | -$0.19 derived: net income ÷ weighted average shares · filed 2017-11-01 | -$0.44 10-Q · filed 2017-11-01 | |
| 2016-07-01 | -$0.15 10-K · filed 2018-02-26 | |||
| 2016-06-30 | -$0.15 10-Q · filed 2017-08-02 | -$0.41 10-Q · filed 2017-08-02 | ||
| 2016-04-01 | -$0.26 10-K · filed 2018-02-26 | |||
| 2016-03-31 | -$0.26 10-Q · filed 2017-05-01 | |||
| 2016-01-01 | -$0.77 10-K · filed 2018-02-26 | |||
| 2013-12-31 | -$1.33 10-K · filed 2014-02-20 | |||
| 2012-12-31 | -$0.92 10-K · filed 2014-02-20 | |||
| 2012-09-30 | -$0.20 10-Q · filed 2012-11-07 | -$0.63 10-Q · filed 2012-11-07 | ||
| 2011-12-31 | $0.35 10-K · filed 2013-02-21 | $0.58 10-K · filed 2014-02-20 | ||
| 2011-09-30 | $0.59 10-K · filed 2013-02-21 | $0.23 10-Q · filed 2012-11-07 | ||
| 2011-06-30 | -$0.16 10-K · filed 2013-02-21 | |||
| 2011-03-31 | -$0.24 10-K · filed 2013-02-21 | |||
| 2010-12-31 | -$0.85 10-K · filed 2013-02-21 | |||
| 2010-09-30 | -$0.08 10-Q · filed 2011-10-27 | -$0.69 10-Q · filed 2011-10-27 | ||
| 2009-12-31 | -$1.26 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |